We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.65%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$59.5B
AUM Growth
+$3.71B
Cap. Flow
+$2.71B
Cap. Flow %
4.55%
Top 10 Hldgs %
19.97%
Holding
3,755
New
295
Increased
1,969
Reduced
1,191
Closed
173

Sector Composition

Rank Sector Weight
1 Technology 10.24%
2 Financials 9.05%
3 Healthcare 7.82%
4 Industrials 6.6%
5 Energy 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCON
3401
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$76K ﹤0.01%
141
-334
-70% -$178K
EOD
3402
Allspring Global Dividend Opportunity Fund
EOD
$286M
$75K ﹤0.01%
13,479
-3,397
-20% -$19.5K
HERZ
3403
Herzfeld Credit Income Fund
HERZ
$31.6M
$74K ﹤0.01%
1,438
NVAX icon
3404
Novavax
NVAX
$1.31B
$73K ﹤0.01%
2,719
-618
-19% -$20.9K
APRN
3405
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$70K ﹤0.01%
116
+43
+59% +$20.3K
TIS
3406
DELISTED
Orchids Paper Products, Inc.
TIS
$70K ﹤0.01%
17,515
-500
-3% -$2.85K
SPY icon
3407
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$69K ﹤0.01%
15,500
-10,200
-40% -$2.75M
AUY
3408
DELISTED
Yamana Gold, Inc.
AUY
$69K ﹤0.01%
23,907
-44,231
-65% -$129K
JCP
3409
DELISTED
J.C. Penney Company, Inc.
JCP
$69K ﹤0.01%
29,469
-2,756
-9% -$7.78K
CCL icon
3410
CALL
Carnival Corporation Ltd
CCL
$39.7B
$68K ﹤0.01%
256,400
+117,000
+84% +$7.42M
DIN icon
3411
CALL
Dine Brands
DIN
$452M
$67K ﹤0.01%
+10,600
New +$767K
PDS
3412
Precision Drilling
PDS
$974M
$66K ﹤0.01%
997
+40
+4% +$2.69K
HTGM
3413
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$64K ﹤0.01%
109
-2
-2% -$1.3K
CTRL
3414
CALL
DELISTED
Control4 Corporation
CTRL
$64K ﹤0.01%
117,100
+48,100
+70% +$1.12M
GNW icon
3415
CALL
Genworth Financial
GNW
$3.71B
$63K ﹤0.01%
+20,000
New +$69K
XXII
3416
22nd Century Group
XXII
$1.48M
0
TA
3417
DELISTED
TravelCenters of America LLC
TA
$57K ﹤0.01%
3,267
-666
-17% -$11.5K
GEN
3418
DELISTED
Genesis Healthcare, Inc.
GEN
$57K ﹤0.01%
25,000
BNFT
3419
CALL
DELISTED
Benefitfocus, Inc.
BNFT
$52K ﹤0.01%
+10,600
New +$332K
VERU icon
3420
Veru
VERU
$37.4M
$51K ﹤0.01%
+2,500
New +$48K
KNDI
3421
Kandi Technologies Group
KNDI
$65.5M
$49K ﹤0.01%
11,600
-1,000
-8% -$5.05K
KERX
3422
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$48K ﹤0.01%
12,671
+500
+4% +$2.43K
AMAT icon
3423
CALL
Applied Materials
AMAT
$428B
$47K ﹤0.01%
29,400
+15,700
+115% +$809K
III icon
3424
Information Services Group
III
$251M
$47K ﹤0.01%
11,512
-5,850
-34% -$24.2K
VIVS
3425
VivoSim Labs
VIVS
$1.64M
$46K ﹤0.01%
135
+21
+18% +$6.92K

Similar funds

Raymond James & Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Raymond James & Associates held 3,755 positions worth $59.5B, up 6.7% from $55.7B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Raymond James & Associates deployed $2.71B of net new capital in Q2 2018, opening 295 new positions and adding to 1,969 existing holdings. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 727,426 shares worth $45.6M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 10% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR Bloomberg High Yield Bond ETF, an estimated $97.9M trimmed.

  • Raymond James & Associates's largest Q2 2018 buy was Vanguard Intermediate-Term Treasury ETF: 727,426 shares worth $45.6M.
  • Raymond James & Associates added most to iShares Core MSCI EAFE ETF in Q2 2018, an estimated $167M increase.
  • Raymond James & Associates's biggest Q2 2018 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $97.9M.
  • Raymond James & Associates fully exited Time Warner Inc in Q2 2018, selling an estimated $118M.
  • Raymond James & Associates's ten largest holdings make up 20% of its $59.5B portfolio in Q2 2018.
  • Raymond James & Associates opened 295 new positions and closed 173 in Q2 2018.
  • Raymond James & Associates's portfolio value rose 6.7% quarter-over-quarter to $59.5B.

Based on Raymond James & Associates's 13F filing for Q2 2018, filed 14 Aug 2018.